380 related articles for article (PubMed ID: 16007090)
1. The crystal structure of human CD1d with and without alpha-galactosylceramide.
Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
[TBL] [Abstract][Full Text] [Related]
2. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.
Fujio M; Wu D; Garcia-Navarro R; Ho DD; Tsuji M; Wong CH
J Am Chem Soc; 2006 Jul; 128(28):9022-3. PubMed ID: 16834361
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for galactosylceramide recognition by CD1-restricted NK T cells.
Brossay L; Naidenko O; Burdin N; Matsuda J; Sakai T; Kronenberg M
J Immunol; 1998 Nov; 161(10):5124-8. PubMed ID: 9820479
[TBL] [Abstract][Full Text] [Related]
5. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.
Kang SJ; Cresswell P
Nat Immunol; 2004 Feb; 5(2):175-81. PubMed ID: 14716312
[TBL] [Abstract][Full Text] [Related]
6. Glycolipid antigen processing for presentation by CD1d molecules.
Prigozy TI; Naidenko O; Qasba P; Elewaut D; Brossay L; Khurana A; Natori T; Koezuka Y; Kulkarni A; Kronenberg M
Science; 2001 Jan; 291(5504):664-7. PubMed ID: 11158680
[TBL] [Abstract][Full Text] [Related]
7. CD1d antigen presentation: treats for NKT cells.
Godfrey DI; McCluskey J; Rossjohn J
Nat Immunol; 2005 Aug; 6(8):754-6. PubMed ID: 16034430
[No Abstract] [Full Text] [Related]
8. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity.
Zajonc DM; Maricic I; Wu D; Halder R; Roy K; Wong CH; Kumar V; Wilson IA
J Exp Med; 2005 Dec; 202(11):1517-26. PubMed ID: 16314439
[TBL] [Abstract][Full Text] [Related]
9. Loading of the antigen-presenting protein CD1d with synthetic glycolipids.
Wallner FK; Chen L; Moliner A; Jondal M; Elofsson M
Chembiochem; 2004 Apr; 5(4):437-44. PubMed ID: 15185366
[TBL] [Abstract][Full Text] [Related]
10. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
Ulrichs T; Porcelli SA
Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
[TBL] [Abstract][Full Text] [Related]
11. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor.
Borg NA; Wun KS; Kjer-Nielsen L; Wilce MC; Pellicci DG; Koh R; Besra GS; Bharadwaj M; Godfrey DI; McCluskey J; Rossjohn J
Nature; 2007 Jul; 448(7149):44-9. PubMed ID: 17581592
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A.
Zajonc DM; Elsliger MA; Teyton L; Wilson IA
Nat Immunol; 2003 Aug; 4(8):808-15. PubMed ID: 12833155
[TBL] [Abstract][Full Text] [Related]
13. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
[TBL] [Abstract][Full Text] [Related]
14. Antigen specificity of semi-invariant CD1d-restricted T cell receptors: the best of both worlds?
Gumperz JE
Immunol Cell Biol; 2004 Jun; 82(3):285-94. PubMed ID: 15186260
[TBL] [Abstract][Full Text] [Related]
15. Structure and binding kinetics of three different human CD1d-alpha-galactosylceramide-specific T cell receptors.
Gadola SD; Koch M; Marles-Wright J; Lissin NM; Shepherd D; Matulis G; Harlos K; Villiger PM; Stuart DI; Jakobsen BK; Cerundolo V; Jones EY
J Exp Med; 2006 Mar; 203(3):699-710. PubMed ID: 16520393
[TBL] [Abstract][Full Text] [Related]
16. The molecular basis of CD1-mediated presentation of lipid antigens.
Moody DB; Besra GS; Wilson IA; Porcelli SA
Immunol Rev; 1999 Dec; 172():285-96. PubMed ID: 10631954
[TBL] [Abstract][Full Text] [Related]
17. [A specific ligand of V alpha 14 NKT cells and its presentation].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
[No Abstract] [Full Text] [Related]
18. A minimal binding footprint on CD1d-glycolipid is a basis for selection of the unique human NKT TCR.
Wun KS; Borg NA; Kjer-Nielsen L; Beddoe T; Koh R; Richardson SK; Thakur M; Howell AR; Scott-Browne JP; Gapin L; Godfrey DI; McCluskey J; Rossjohn J
J Exp Med; 2008 Apr; 205(4):939-49. PubMed ID: 18378792
[TBL] [Abstract][Full Text] [Related]
19. Generation of CD1 tetramers as a tool to monitor glycolipid-specific T cells.
Gadola SD; Karadimitris A; Zaccai NR; Salio M; Dulphy N; Shepherd D; Jones EY; Cerundolo V
Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):875-7. PubMed ID: 12803920
[TBL] [Abstract][Full Text] [Related]
20. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts.
Lang GA; Maltsev SD; Besra GS; Lang ML
Immunology; 2004 Jul; 112(3):386-96. PubMed ID: 15196206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
